Biotech · Private company
Paidion Research, Inc.
Track this companyFree. Adds Paidion Research, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials100 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials10
- Growth and Safety Clinical Trial on a New Infant Formula.NA · COMPLETED · started Feb 12, 2021ClinicalTrials.gov NCT04671576 · fetched Nov 12, 2026
- Phase II Growth and Safety Study of an Infant Formula for Healthy Term InfantsNA · COMPLETED · started Oct 14, 2020ClinicalTrials.gov NCT04593147 · fetched Nov 12, 2026
- Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term InfantsNA · COMPLETED · started May 12, 2020ClinicalTrials.gov NCT04389606 · fetched Nov 12, 2026
- Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term InfantsNA · COMPLETED · started Dec 10, 2019ClinicalTrials.gov NCT04218929 · fetched Nov 12, 2026
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsPHASE2 · COMPLETED · started Jun 25, 2019ClinicalTrials.gov NCT03981822 · fetched Nov 12, 2026
- Cantharidin and Occlusion in Verruca EpitheliumPHASE2 · COMPLETED · started Mar 27, 2018ClinicalTrials.gov NCT03487549 · fetched Nov 12, 2026
- Cantharidin Application in Molluscum Patients-1PHASE3 · COMPLETED · started Mar 21, 2018ClinicalTrials.gov NCT03377790 · fetched Nov 12, 2026
- Cantharidin Application in Molluscum PatientsPHASE3 · COMPLETED · started Feb 14, 2018ClinicalTrials.gov NCT03377803 · fetched Nov 12, 2026
- Growth and Safety Study of an Infant Formula for Healthy Term InfantsNA · COMPLETED · started Sep 18, 2017ClinicalTrials.gov NCT03331276 · fetched Nov 12, 2026
- Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.PHASE2 · COMPLETED · started Jun 8, 2017ClinicalTrials.gov NCT03186378 · fetched Nov 12, 2026